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Abstract
Background:  During skeletogenesis, protein levels of β-catenin in the canonical Wnt signaling pathway
determine lineage commitment of skeletal precursor cells to osteoblasts and chondrocytes. Adenomatous
polyposis coli (Apc) is a key controller of β-catenin turnover by down-regulating intracellular levels of β-catenin.
Results: To investigate whether Apc is involved in lineage commitment of skeletal precursor cells, we generated
conditional knockout mice lacking functional Apc in Col2a1-expressing cells. In contrast to other models in which
an oncogenic variant of β-catenin was used, our approach resulted in the accumulation of wild type β-catenin
protein due to functional loss of Apc. Conditional homozygous Apc mutant mice died perinatally showing greatly
impaired skeletogenesis. All endochondral bones were misshaped and lacked structural integrity. Lack of
functional Apc resulted in a pleiotropic skeletal cell phenotype. The majority of the precursor cells lacking Apc
failed to differentiate into chondrocytes or osteoblasts. However, skeletal precursor cells in the proximal ribs
were able to escape the noxious effect of functional loss of Apc resulting in formation of highly active osteoblasts.
Inactivation of Apc in chondrocytes was associated with dedifferentiation of these cells.
Conclusion: Our data indicate that a tight Apc-mediated control of β-catenin levels is essential for differentiation
of skeletal precursors as well as for the maintenance of a chondrocytic phenotype in a spatio-temporal regulated
manner.
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Background
During vertebrate embryogenesis, the axial and appendic-
ular skeleton develop through endochondral bone forma-
tion. In this process, mesenchymal cells aggregate to form
a chondrocytic template that prefigures the shape of the
future bone. At the periphery of this cartilaginous mold,
osteoblasts differentiate to form the bone collar. The car-
tilaginous mold is eventually replaced by bone in a step-
wise program. Besides chondrocytes and osteoblasts, the
skeleton also contains osteoclasts, which are of haemat-
opoietic origin and play pivotal roles in both cartilage and
bone resorption and remodelling [1-3].
Every step in the proliferation, differentiation, matura-
tion, apoptosis, and resorption of both chondrocytes and
osteoblasts is characterized by a specific transcriptional
guideline [4]. Sox9, a high-mobility-group transcription
factor, and Runx2, a Runt domain transcription factor, are
both expressed in bi-potential skeletal precursor cells dif-
ferentiating into either chondrocytes or osteoblasts [5-7].
Sox9 and Runx2 play leading roles in lineage commit-
ment of these precursors: upregulation of Sox9 leads to
chondrogenic differentiation [8], while activation of
Runx2 is required for their osteogenic commitment [9].
Recently, based on mouse models, the canonical Wnt/β-
catenin signaling pathway was found to act upstream of
Sox9 and Runx2. In this pathway, in the absence of a Wnt
signal, cytosolic β-catenin is degraded by the ubiquitina-
tion/proteasome system upon its phosphorylation at spe-
cific Ser-Thr residues by a destruction complex consisting
of scaffold proteins such as Axin1, Axin2 (also known as
Conductin) and the adenomatous polyposis coli (APC)
tumor suppressor, and two kinases, namely glycogen syn-
thase kinase 3β (GSK3β) and casein-kinase 1α (CK1α).
Binding of Wnt to a complex composed of the transmem-
brane frizzled receptor and low-density lipoprotein recep-
tor-related protein 5 or 6 (LRP5 or 6) co-receptor results
in inactivation of the destruction complex and accumula-
tion of cytoplasmic β-catenin. Upon its nuclear transloca-
tion,  β-catenin acts as transcriptional co-activator in
complex with transcription factors of the TCF/LEF family,
leading to transcriptional activation of Wnt target genes
[10]. In wild type mouse embryos, high levels of β-catenin
and activation of canonical Wnt signaling have been
found in osteoblastic precursors in developing skull and
limb bones [11]. Accumulating evidence suggests that
increased levels of canonical Wnt/β-catenin signaling
inhibit Sox9 expression and activity, and stimulate Runx2
expression, leading to decreased chondrocyte differentia-
tion and increased osteoblast differentiation, respectively
[12-15]. Similar results have been found in transgenic
mice with Wnt14 overexpression in Collagen 2a1 (Col2a1)-
expressing cells [11].
It has been also demonstrated that β-catenin is required at
an early stage to repress chondrocytic differentiation [15].
Upon conditional inactivation of β-catenin in the limb
and head mesenchyme before or during early mesenchy-
mal condensations, Prx1-expressing and Dermo1-express-
ing skeletal precursors, respectively, differentiate into
chondrocytes instead of osteoblasts [11,15]. Finally,
results on both constitutively active and inactivated β-cat-
enin in Osterix (Osx)-, Collagen 1a1 (Col1a1)- or Osteocal-
cin  (Osc)-expressing osteoblasts suggest that Wnt/β-
catenin signaling coordinates bone formation by control-
ling the differentiation and activity of both osteoblasts
and osteoclasts in a sequential, stage-specific manner
[16,17].
Little is known about the mechanisms regulating β-cat-
enin activity in skeletal precursors. Through its wide range
of specific motifs and domains, APC is involved in multi-
ple cellular processes such as signal transduction,
cytoskeletal organization, apoptosis, cell adhesion and
motility, cell fate determination, and chromosomal sta-
bility [18]. However, biochemical and genetic evidence
has been provided showing that APC's main tumor sup-
pressing activity resides in its ability to bind to β-catenin
and induce its degradation, thereby acting as a strong neg-
ative regulator of the canonical Wnt pathway [19-21].
Familial adenomatous polyposis (FAP) patients hetero-
zygous for an APC mutation frequently develop osteomas
and dental anomalies [22]. Heterozygous Apc1638N mutant
mice occasionally develop osteomas (R. Fodde, personal
communication). Homozygosity for the severely trun-
cated  ApcMin  and for the more hypomorphic Apc1638N
allele in the mouse results in a failure of primitive ecto-
derm development shortly after implantation, leading to
lethality prior to gastrulation [23,24]. Mutant Apc dis-
turbs the differentiation capacity of mouse embryonic
stem (ES) cells in a quantitative and qualitative fashion
depending on the dose of β-catenin signaling. Aberrant
differentiation capacity of ES cells ranges from a strong
differentiation blockade in case of two severely truncated
ApcMin alleles, to more specific neuroectodermal, dorsal
mesodermal, and endodermal defects (e.g., no differenti-
ation in bone or cartilage) in case of two hypomorphic
Apc1638N alleles [25,26]. Osteoblast-specific loss of Apc in
the mouse leads to early onset of dramatically increased
bone deposition and to lethality early in life [17]. How-
ever, Apc has not yet been linked with a role in the differ-
entiation of skeletal precursor cells.
Here, we report that skeletal precursors of the axial and
appendicular skeleton, when exposed to an uncontrolled
rise of the β-catenin level due to conditional inactivation
of Apc, lose their differentiation capacity to both the chon-BMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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drogenic and osteogenic lineage. Moreover, conditional
Apc mutant ribs show enhanced osteoblast activity, while
the mutant nasal septum displays chondrocyte dedifferen-
tiation. These results provide the first genetic evidence
that Apc plays a crucial role throughout mouse skele-
togenesis by regulating the differentiation of skeletal pro-
genitor cells and maintenance of chondrocytes.
Results
Conditional Apc15lox mice and transgenic Col2a1-Cre mice
Recently, we (ECR-M and RF) generated a novel mouse
model carrying a conditional Apc15lox allele where exon
15, encoding the majority of the coding region of Apc, and
the polyadenylation signal, is flanked by loxP sites. Mice
heterozygous and homozygous for the conditional
Apc15lox allele did not show any major abnormalities or
susceptibility to tumors. ApcΔ15/+mice, heterozygous for
the ApcΔ15mutant allele obtained by germline Cre-medi-
ated deletion of exon 15, developed multiple intestinal
tumors at an early age similar to ApcMin/+animals. These
results indicate that Cre-mediated recombination of the
Apc15lox allele leads to inactivation of the Apc protein and
to the constitutive activation of Wnt/β-catenin signaling
(Robanus-Maandag et al., in preparation).
Next, we investigated the temporal and spatial expression
pattern of Cre in transgenic Col2a1-Cre mice [27] using
LacZ reporter mice ("Rosaflox") [28]. Col2a1-Cre;Rosa-
flox embryos expressed Cre specifically at all sites of endo-
chondral bone formation (Fig. 1A). In accordance with
previous studies suggesting that Col2a1  is already
expressed at E9.5 in the sclerotome of the somites [29], we
detected Cre activity (based on positive LacZ staining) in
mesenchymal condensations forming the sclerotome at
E9.5 (Fig. 1B). At E12.5, LacZ-positive cells were identified
in cartilage primordia later forming the vertebrae, long
bones, sternum and cranial bones (Fig. 1C; data not
shown). As reported in other Col2a1-Cre  mouse lines
[11,30], we found LacZ staining in the perichondrium at
E14.5 (data not shown), and in the periosteum and pri-
mary spongiosa of long bones at E16.5, sites where oste-
oblasts normally differentiate (Fig. 1D, D'). The early
onset (E9.5) of the LacZ expression in the sclerotome as
well as its presence at later developmental stages (E14.5
and E16.5) in cells of the osteogenic lineage prompted us
to conclude that the Col2a1-Cre-mediated recombination
occurred in skeletal precursors characterized by both a
chondrogenic and osteogenic differentiation potential.
Heterozygous Apc15lox/+ mice do not show any skeletal 
defect upon Col2a1-driven Cre expression
Apc15lox/15lox mice were bred with Col2a1-Cre mice to gen-
erate conditional heterozygous Col2a1-Cre;Apc15lox/+
mice. Microscopical analysis performed on Col2a1-
Cre;Apc15lox/+ and control Apc15lox/+ embryos at various
developmental stages (E12.5, E14.5, E16.5) displayed a
normal spatio-temporal expression of all chondrogenic
and osteogenic markers investigated (data not shown).
To study postnatal growth and bone acquisition, 18
Col2a1-Cre;Apc15lox/+ mice (7 males, 11 females) and 11
Apc15lox/+ mice (7 males, 4 females) were monitored for 12
weeks after birth. Mice of both genotypes were healthy,
similar in appearance, size, body length/weight ratio and
growth rate (data not shown). We next assessed bone
architecture in these animals by micro-computed tomog-
raphy (μCT) of the distal femora. No difference was
detected between Col2a1-Cre;Apc15lox/+ mice and gender-
matched Apc15lox/+ control littermates with respect to bone
mineral density, trabecular bone volume fraction, trabec-
ular number, trabecular thickness, and trabecular separa-
tion (Fig. 2A–D; data not shown). We further wanted to
study whether conditional heterozygous Apc inactivation
would lead to skeletal anomalies later in life. For this pur-
pose, 10 Col2a1-Cre;Apc15lox/+  mice (5 males and 5
females) and 5 Apc15lox/+ male mice were followed for 24
months. At the end of this period, animals were sacrificed
and tissues were analyzed microscopically using hematox-
iline/eosine-stained sections. No important abnormalities
Col2a1-Cre;Rosaflox mice express Cre at sites of endochon- dral bone formation Figure 1
Col2a1-Cre;Rosaflox mice express Cre at sites of 
endochondral bone formation. (A-D) LacZ expression in 
Col2a1-Cre;Rosaflox embryos following Cre recombination, 
detected by whole-mount X-Gal staining. (A) Macroscopic 
picture of E12.5 Col2a1-Cre;Rosaflox embryo. (B) Transver-
sal section of E9.5 embryo showing β-galactosidase-positive 
sclerotomal cells adjacent to the neural tube. (C) Transversal 
section of E12.5 embryo showing LacZ expression in verte-
brae primordia. (D) Sagital section of E16.5 embryo showing 
LacZ expression in the femur. The boxed region in D is mag-
nified in D' showing LacZ expression in the periosteum 
(arrow head), osteoblasts (red arrow) and osteocytes (black 
arrow). Ne, neuroepithelium; Sc, sclerotome; N, notochord; 
Fe, femur. Scale bars: 1 mm in A; 50 μm in B, D'; 100 μm in 
C, D.BMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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could be distinguished in the skull, ribs, vertebral column
and long bones. We evenly detected in both groups signs
of cartilage degradation, fibrosis, and osteochondritis,
pathological findings which most likely were all age-
related (data not shown). Altogether, we considered con-
ditional heterozygous Apc mutant embryos as controls for
the next experiments.
Homozygous Col2a1-Cre;Apc15lox/15lox mice die perinatally 
due to severe defects in skeletogenesis
Col2a1-Cre;Apc15lox/+ mice were crossed with Apc15lox/15lox
mice to generate conditional homozygous Col2a1-
Cre;Apc15lox/15lox  mice (1:4). None of these mice were
found at one month of age among 77 liveborn offspring.
Of 27 dead pups found within the first month after deliv-
ery, only 5 pups on the day after delivery were Col2a1-
Cre;Apc15lox/15lox. To further investigate the Col2a1-
Cre;Apc15lox/15lox phenotype, embryonic litters at various
developmental stages were isolated. Eight of 31 embryos
isolated between E16.5 and E19.5 were Col2a1-
Cre;Apc15lox/15lox (26%). We concluded that conditional
homozygosity for this Apc mutant allele was perinatally
lethal. At E12.5, Col2a1-Cre;Apc15lox/15lox  embryos,
although normal in size, displayed poor mandible and
limb outgrowth compared to control littermates (Fig. 3A).
At E14.5 and E16.5, Col2a1-Cre;Apc15lox/15lox  embryos
were much smaller in comparison to controls, displayed
craniofacial abnormalities, short trunk, and an incom-
plete closure of both thoracic and abdominal cavities (Fig.
3B, C). Gross analysis further indicated a severe trunca-
tion of both upper and lower limbs. Already at E14.5, but
more significantly at E16.5, Col2a1-Cre;Apc15lox/15lox
embryos presented large skin blisters especially in the
dorso-lumbar region (Fig. 3C).
Skeletal preparations of mouse embryos stained with
Alcian blue (chondrocyte matrix) and Alizarin red (min-
eralized matrix) of embryos at E14.5 revealed a clear dif-
ference in size between Col2a1-Cre;Apc15lox/15lox mutants
and control littermates (Fig. 3D). All mutant structures
were severely misshaped and fragmented. Mutants failed
to develop a cartilaginous mold of both the mandibles
and the occipital bone. The axial skeleton contained
patchy and irregular cartilaginous structures that did not
organize in vertebrae. All 13 rib pairs could be individu-
ally distinguished, however, due to their inadequate ori-
entation, size, and shape and due to lack of a sternum, no
thoracic basket was formed (Fig. 4A, B). Distorted carti-
lage rudiments were found where forelimbs should nor-
mally arise (Fig. 4E, F), while no signs of bone formation
were found in hindlimb rudiments. Furthermore, no car-
tilaginous primordia of pelvic bones were observed. Sim-
ilar observations were made in Col2a1-Cre;Apc15lox/15lox
embryos at E16.5 (Fig. 3E). At this developmental stage
however, distinct areas of mineralization were observed in
most parts of the mutant skeleton. The mutant hind skull
showed mineralized regions, whereas the control occipital
and temporal bone primordias stained only with Alcian
blue (Fig. 4I, J). Mutant proximal ribs in these Col2a1-
Cre;Apc15lox/15lox embryos were much thicker and shorter
in comparison to those in control embryos, and stained
intensively with Alizarin red (Fig. 4C, D). In the mutant
forelimb, a hypoplastic scapula could be identified,
whereas more distal components were agenetic and
replaced by an irregular cartilaginous structure (Fig. 4G,
H).
Loss of functional Apc inhibits differentiation of skeletal 
precursors
Lack of functional Apc results in accumulation of cyto-
plasmic β-catenin, which subsequently translocates into
the nucleus. This process can be well detected by immu-
nohistochemistry (IHC). To investigate endochondral
bone formation in Col2a1-Cre;Apc15lox/15lox embryos, we
analyzed vertebra formation at E12.5 and E14.5, and
humerus development at E16.5 using IHC for β-catenin in
combination with Alcian blue staining, and in situ hybrid-
ization (ISH) for several chondrocyte- and osteoblast-spe-
cific genes. Strongly elevated levels of β-catenin were seen
at all sites of endochondral ossification in the Col2a1-
Skeletal development occurs normally in Col2a1-Cre;Apc15lox/ + mice Figure 2
Skeletal development occurs normally in Col2a1-
Cre;Apc15lox/+ mice. (A-D) μCT analysis of the distal diaphy-
sis of the femur did not reveal significant differences between 
12-week-old Col2a1-Cre;Apc15lox/+ mice and control litterma-
tes in any of the parameters investigated: (A) trabecular bone 
volume [BV/TV (%)], (B) number of trabeculae [Tb.N (1/
mm)], (C) trabecular thickness [Tb.Th (μm)], and (D) trabec-
ular separation [Tb.Sp (mm)]. All data represent mean values 
± s.dBMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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Cre;Apc15lox/15lox embryos at E12.5, E14.5 and E16.5, indi-
cating efficient Col2a1-Cre-mediated Apc inactivation.
At E12.5, transversal sections of control vertebral primor-
dia showed normal mesenchymal cell condensation and
subsequent chondrogenic differentiation (Fig. 5A–C).
Chondrocytes stained negatively for β-catenin, started to
deposit an Alcian blue-stained matrix, and expressed the
nascent chondrocyte markers Sox9 and Col2a1. In marked
contrast, mutant sclerotomal cells failed to condense into
skeletal primordias. They showed strong nuclear β-cat-
enin staining and displayed a mesenchymal-like spindle
shape morphology. These cells expressed neither Sox9, nor
Col2a1, implying that conditional loss of functional Apc
in skeletal precursors inhibited mesenchymal cell conden-
sation and chondrogenic differentiation. Next, we investi-
gated whether these cells had switched their commitment
to the osteogenic lineage due to the accumulation of β-cat-
enin. Surprisingly, they did not express the early osteob-
last markers Runx2 and Col1a1, suggesting that β-catenin
accumulation due to Apc inactivation impaired osteogenic
differentiation of skeletal precursors as well (Fig. 5D, E).
At E14.5, chondrocytes in the control vertebrae did not
stain positively for β-catenin, displayed an intensely
Alcian blue-stained matrix and expressed both early (Sox9,
Col2a1) and mature chondrocyte markers, like Indian
hedgehog (Ihh) and Collagen 10a1 (Col10a1), indicating a
normal progression of endochondral ossification (Fig.
5F–J). Although somite formation was present, mutant
vertebrae were heavily crumbled and failed to organize in
a cartilaginous anlage. Occasionally Alcian blue-positive
clusters of chondrocytes were seen, which lacked detecta-
ble  β-catenin immunostaining and were positive for
chondrogenic marker expression. These cells were proba-
bly derived from non-recombined cells due to mosaicism
of  Cre  expression. Surrounding these cartilage islands,
mesenchymal-like spindle-shaped cells were observed.
Comparable to the defects observed at E12.5, these cells
expressed high levels of nuclear β-catenin due to Apc inac-
tivation and lacked not only an Alcian blue-positive
matrix but also expression of both chondrogenic and oste-
ogenic markers (Fig. 5F–J; data not shown).
At E16.5, chondrocytes of control proximal humeri did
not express detectable β-catenin protein levels and were
surrounded by a proteoglycan-rich matrix, which stained
positively with both Alcian blue and Toluidine blue (Fig.
6A, B). They were organized in growth plates with a char-
acteristic spatial expression pattern of the chondrogenic
markers  Sox9,  Col2a1,  Ihh, and Col10a1  (Fig. 6C–F).
Young osteoblasts in the perichondrium, periosteum and
Skeletogenesis is severely impaired in Col2a1-Cre;Apc15lox/15lox embryos Figure 3
Skeletogenesis is severely impaired in Col2a1-Cre;Apc15lox/15lox embryos. (A-E) Greatly impaired skeletal development 
and growth arrest of Col2a1-Cre;Apc15lox/15lox embryos. Gross appearance (A-C) and Alcian blue and Alizarin red staining (D-E) 
of skeletal preparations of Col2a1-Cre;Apc15lox/15lox embryos and control littermates at indicated developmental stages. Condi-
tional Apc mutants showed lack of mandible outgrowth (arrowheads), poor limb development (black arrows), and an open tho-
racic and abdominal cavity (red arrows). Scale bars: 1 mm.BMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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Details of skeletal preparations Figure 4
Details of skeletal preparations. (A-D) Vertebral column of control and mutant littermates at E14.5 (A, B) and E16.5 (C, 
D). Mutant vertebrae lacked structural integrity (arrowheads). At E16.5, mineralization was enhanced in the proximal part of 
the mutant rib (arrow). (E-H) Forelimb of control and mutant littermates at E14.5 (E, F) and E16.5 (G, H). At E16.5, only the 
scapula was identified (arrowhead), while more distal parts were represented by patchy cartilage aggregations (arrow). (I, J) 
Skull of control and mutant littermates at E16.5. The mutant displayed mineral deposition in the back skull corresponding to 
the cartilaginous structure in the control (arrowheads). Scale bars: 3 mm in A-H; 1 mm in I, J.BMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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primary spongiosa were surrounded by a mineralized
osteoid as detected by von Kossa staining (Fig. 6B) and
expressed Runx2 and Col1a1 (Fig. 6G, H). Mature osteob-
lasts expressed Osc (Fig. 6I), while osteoclasts expressed
Matrix metalloproteinase 9 (Mmp9) (Fig. 6J). In contrast,
mutant humeri were completely misshaped and con-
tained nuclear β-catenin-positive cells that were organized
in clusters, showing a mesenchymal-like shape (Fig. 6A).
Similar to our observations at E12.5 and E14.5, these cells
expressed neither chondrogenic, nor osteogenic markers
(Fig. 6C–I). In addition, no Mmp9 expression could be
detected (Fig. 6J), suggesting that differentiation of bone-
resorbing cells was impaired as well. These β-catenin-pos-
itive cell clusters were surrounded by chondrocytes
expressing Sox9 and Col2a and lacked positive staining for
β-catenin. These cell most likely have not undergone a
recombination event as observed at E14.5 (Fig. 6A, C, D).
Abnormal axial skeleton formation of Col2a1-Cre;Apc15lox/15lox embryos already detectable at E12.5 Figure 5
Abnormal axial skeleton formation of Col2a1-Cre;Apc15lox/15lox embryos already detectable at E12.5. (A) Immu-
nostaining for β-catenin combined with Alcian blue (AB) staining, and (B-E) gene expression analysis by in situ hybridization 
with indicated probes on consecutive transversal sections of the sclerotome of a Col2a1-Cre;Apc15lox/15lox embryo and control 
littermate at E12.5. (F-J) Similar analysis of vertebrae primordia at E14.5. β-Catenin-positive spindle-shaped cells lacked expres-
sion of all indicated chondrogenic and osteogenic markers (arrowheads). Scale bars: 100 μm.BMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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Increased osteoblastogenesis in proximal ribs of Col2a1-
Cre;Apc15lox/15lox embryos
Despite the inhibitory effect of Apc inactivation on differ-
entiation of skeletal precursors in long bones and verte-
brae, proximal ribs of Col2a1-Cre;Apc15lox/15lox embryos at
E16.5 showed clearly enhanced mineralization upon skel-
etal staining (Fig. 4D). Therefore, we analyzed the devel-
opment of these skeletal structures in more detail. The ribs
develop through endochondral ossification from the
paired lateral sclerotomic areas [31]. Formation of the
proximal rib depends on the notochord and the ventral
neural tube, whereas development of the distal part
depends on the surface ectoderm [32]. At E14.5, proximal
ribs of control embryos were cartilaginous and contained
mature chondrocytes that did not stain for β-catenin (Fig.
7A–C). Mutant proximal ribs were severely misshaped
and contained β-catenin negatively stained cartilage
islands, accounting for the positive Alcian blue staining
observed upon skeletal preparation (Fig. 4B, 7A). β-Cat-
enin-positive cells were negative for chondrogenic and
osteogenic markers (Fig. 7A–D). At E16.5, the β-catenin-
negative proximal ribs of control embryos consisted of
cartilage and mineralized bone matrix as indicated by
combined von Kossa-Toluidine blue staining (Fig. 7E, F;
data not shown). They contained chondrocytes, osteob-
lasts, and osteoclasts as assessed by ISH (Fig. 7H–K; data
not shown). In contrast, proximal ribs of mutant litterma-
tes stained strongly positive for β-catenin and were signif-
icantly thicker and shorter compared to those of control
embryos (Fig. 4C, D and 7E–G). They consisted of a mas-
sive mineralized bone matrix and a poorly developed
bone marrow cavity, although osteoclast differentiation
and activity were normal as assessed by ISH for Mmp9 and
TRAP staining, respectively (Fig. 7K, L, L'). Interestingly, β-
catenin-positive cells expressed all osteogenic markers
analyzed (Runx2, Col1a1, and Osc), indicating that, unlike
in the long bones and vertebrae, Apc inactivation in skele-
tal precursors of the proximal ribs did not impair osteob-
lastogenesis (Fig. 7H–J). Since Ihh is a critical regulator of
osteoblastogenesis, we subsequently tested whether the
increased ossification might be due to increased Ihh
expression in the non-recombined neighbouring
chondrocytes. The β-catenin-negative cells, however,
matured normally expressing all chondrocyte markers
investigated (Sox9, Col2a1, Ihh and Col10a1) at similar lev-
els compared to control cartilage (data not shown). The
abundant presence of a bone matrix combined with evi-
dence of functional osteoclasts suggested that the β-cat-
enin-positive osteoblasts were sclerotic.
Chondrocyte dedifferentiation in the nasal septum of 
Col2a1-Cre;Apc15lox/15lox embryos
The nasal septum is a midline vertical plate of hyaline car-
tilage, which undergoes endochondral ossification in
postnatal life [33]. Endochondral ossification of the cau-
dal and dorsal borders of the septum, when combined
No chondrogenic and osteogenic differentiation in the developing humerus due to lack of functional Apc Figure 6
No chondrogenic and osteogenic differentiation in the developing humerus due to lack of functional Apc. (A-B) 
Immunostaining for β-catenin combined with Alcian blue (AB) staining (A), combined von Kossa-Toluidine blue staining (B), and 
(C-J) gene expression analysis by in situ hybridization with indicated probes for (C-F) chondrocytes, (G-I) osteoblasts and (J) 
osteoclasts on consecutive transversal sections of the developing humerus of a Col2a1-Cre;Apc15lox/15lox embryo and control lit-
termate at E16.5. β-Catenin-positive spindle-shaped cells organized in clusters and failed to express chondrogenic and osteo-
genic markers (arrowheads). β-Catenin-negative cells at the periphery of these clusters expressed early chondrogenic markers 
only (arrows), probably due to lack of Cre-mediated loss of functional Apc. Scale bars: 100 μm.BMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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Conditional Apc inactivation enhances osteoblast formation and mineral deposition in the developing proximal rib Figure 7
Conditional Apc inactivation enhances osteoblast formation and mineral deposition in the developing proximal 
rib. (A-L) Immunostaining for β-catenin combined with Alcian blue (AB) staining (A, E), combined von Kossa-Toluidine blue 
staining (F), hematoxylin/eosin staining (G), gene expression analysis by in situ hybridization with indicated probes for chondro-
genic (B, C), osteogenic (D, H-J) and osteoclastogenic differentiation (K) on consecutive transversal sections of the developing 
proximal rib of a Col2a1-Cre;Apc15lox/15lox embryo and control littermate at E14.5 (A-D) and E16.5 (E-K). The double-headed 
arrows in G indicate the thickness of the rib. (L) Tartrate-resistant acid phosphatase (TRAP) staining of the developing proxi-
mal rib of a Col2a1-Cre;Apc15lox/15lox embryo at E16.5. The boxed region in L is magnified in L' showing multinucleated osteo-
clasts (arrowheads) staining positive for TRAP. Scale bars: 100 μm in A-L; 50 μm in L'.BMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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with interstitial expansion, has the effect of displacing the
facial skeleton away from the neurocranium and thus
enlarging the skull [34]. At E16.5, chondrocytes forming
the nasal septum of control mice did not stain for β-cat-
enin, were surrounded by an Alcian blue-positive matrix,
and expressed Sox9 and Col2a1 (Fig. 8A–D). In the mutant
nasal cartilage we distinguished crumbled chondrogenic
islands surrounded by β-catenin-positive cells with an
undifferentiated mesenchymal-like phenotype (Fig. 8F–
H). The chondrogenic islands consisted of round cells
embedded in chondrons surrounded by extracellular
matrix (ECM) (Fig. 8E). Interestingly, molecular analysis
of these chondrogenic islands revealed the presence of
two cell populations: β-catenin-negative and β-catenin-
positive cells. The former expressed chondrogenic markers
like Sox9 and Col2a1, and their ECM stained positive with
Alcian blue, whereas the latter did not express any chon-
drogenic or osteogenic markers, while their ECM stained
significantly less with Alcian blue (Fig. 8F–I; data not
shown).
The presence of β-catenin-positive cells in the chondro-
genic islands suggested that these cells, due to mosaicism
of Cre expression, had initiated normal chondrocyte dif-
ferentiation before undergoing Apc  inactivation. Subse-
quently, the increased level of β-catenin triggered the loss
of expression of the early chondrogenic markers and initi-
ated degradation of the ECM. These observations were
indicative of dedifferentiated chondrocytes. Similar obser-
vations were made in cartilaginous rudiments at other
sites of endochondral bone formation, but the effect was
most pronounced in the nasal septum (data not shown).
Discussion
Conditional homozygous loss of functional Apc severely 
disrupts mouse skeletogenesis via stabilized β-catenin
According to most of the transgenic mouse studies
reported, levels of β-catenin, the effector of the canonical
Wnt ligands, need to be downregulated in skeletal precur-
sor cells to enable chondrogenic differentiation, whereas
elevated  β-catenin levels promote differentiation into
Dedifferentiation in the nasal septum of Col2a1-Cre;Apc15lox/15lox embryos at E16.5 Figure 8
Dedifferentiation in the nasal septum of Col2a1-Cre;Apc15lox/15lox embryos at E16.5. (A, E) Hematoxylin/eosin stain-
ing, (B, F, H) immunostaining for β-catenin combined with Alcian blue (AB) staining, and (C-D, G, I) gene expression analysis by 
in situ hybridization with indicated probes for chondrogenic differentiation on consecutive transversal sections of the develop-
ing nasal septum of a Col2a1-Cre;Apc15lox/15lox embryo and control littermate at E16.5. (F', G', H', I') High magnification pictures 
of the boxed regions in F, G, H, and I, respectively. Mesenchymal-like β-catenin-positive cells (arrow in F, H) were present 
between crumbled cartilage islands. Within these cartilage islands, although displaying chondrocytic morphology and an Alcian 
blue stained matrix, most of the β-catenin-positive cells did not express Sox9 (arrowheads in G') or Col2a1 (arrows in I'). Scale 
bars: 100 μm in A, E, F, H; 5 μm in F', H'.BMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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osteoblasts [11,12,15,35,36]. This theory is partly based
on observations in heterozygous gain-of-function models
in which Cre-mediated recombination results in the
expression of oncogenic β-catenin. The cellular mecha-
nisms controlling the biological effects of oncogenic β-
catenin in the presence of wild type β-catenin are largely
unknown. In addition, there are no reports on the role of
Apc in regulation of skeletal precursor differentiation via
control of β-catenin in the mouse. Here, we have focused
on this important role of the multifunctional protein Apc,
binding to and downregulating β-catenin. We have selec-
tively inactivated one or both alleles of Apc in murine
Col2a1-expressing cells. Our data indicate that the Col2a1
promoter is suitable for this study, since Cre-mediated
recombination starts very early (E9.5) in skeletal precur-
sor cells that have not yet committed to the chondrogenic
or the osteogenic lineage, consistent with previous find-
ings in other Col2a1-Cre lines [11,30].
Conditional heterozygous inactivation of Apc does not
result in a detectable level of its target β-catenin as deter-
mined by IHC. Moreover, heterozygous Col2a1-Cre-
mediated Apc inactivation does not interfere with embry-
onic skeletal development, postnatal growth or bone
acquisition up to 24 months of age, as determined by his-
tological and μCT analysis. Our data imply that the level
of Apc protein produced by a single functional Apc allele
is sufficient to mediate appropriate β-catenin degradation.
This is in agreement with normal body weight, size, and
growth of young ApcMin/+ mice [37].
In marked contrast, conditional inactivation of Apc results
in a strongly elevated level of (wild type) β-catenin in skel-
etal precursors, leading to greatly impaired embryogenesis
and perinatal lethality. The significantly reduced size and
the vast range of skeletal malformations in these embryos
is most likely due to the specific Col2a1-Cre activity in
skeletal primordias at a very early embryonic stage starting
at E9.5 resulting in massive β-catenin accumulation in the
developing endochondral skeleton. Probably several fac-
tors, like the open rib cage and the severe malformation,
from E14.5 on have led to the perinatal lethality. The loss
of the multiple β-catenin-independent functions of the
Apc protein might have contributed to the gravity and
complexity of the skeletal phenotype observed in Col2a1-
Cre;Apc15lox/15lox mice as well [18]. Moreover, since Col2a1
expression is not completely restricted to skeletal tissues
during mouse embryogenesis [29], we can not exclude
that the severity of the phenotype might have been partly
due to loss of functional Apc in other Col2a1-Cre-express-
ing cell types.
Apc is crucial for both chondrogenic and osteogenic 
differentiation of skeletal precursors
Wnt/β-catenin signaling represents a mechanism in mes-
enchymal precursor cells for selecting between chondro-
cytic and osteoblastic fates. This key regulating role in
lineage commitment has been attributed to β-catenin.
Indeed, conditional gain-of-function mutation of β-cat-
enin  leads to decreased chondrocyte differentiation in
Prx1-expressing and Col2a1-expressing cells [12,15]. How-
ever, corresponding increased osteoblast differentiation
has not been observed in these models, instead, a
decreased osteoblast marker expression has been seen in
case of Prx1-expressing cells, suggesting that activation of
β-catenin negatively affects skeletogenesis [12,15]. In
addition, conditional loss-of-function mutation of β-cat-
enin in Prx1-expressing cells leads to increased expression
of not only chondrocyte but also early osteoblast markers
[15]. These data strongly suggest that β-catenin negatively
regulates the differentiation of mesenchymal cells into a
common skeletal precursor [38].
We report here that in the vast majority of endochondral
skeletal elements, precursor cells lacking functional Apc
express strong nuclear β-catenin staining and fail to differ-
entiate into both chondrogenic and osteogenic lineages.
These data are in line with the inability of mouse embry-
onic stem cells carrying specific bi-allelic Apc mutations to
differentiate into bone and cartilage [25]. Our data are
also consistent with those based on conditional stabiliza-
tion of β-catenin in mesenchymal skeletal precursors
which had an undifferentiated appearance [15]. This con-
sistency strongly suggests that, notwithstanding the multi-
ple functions of Apc, its β-catenin-controlling role is the
most important during skeletogenesis. We conclude that
Apc plays a crucial role in differentiation of skeletal pre-
cursors in vertebrae and long bones: it enables the differ-
entiation into both skeletal lineages by decreasing the
level of β-catenin.
Loss of functional Apc in skeletal precursors of the 
proximal rib stimulates osteogenesis
Although in the vast majority of the endochondral skele-
ton both chondrogenic and osteogenic differentiation is
inhibited due to loss of functional Apc in skeletal precur-
sors, we find a different phenotype in the proximal ribs.
Notwithstanding the cartilaginous structure at E14.5,
proximal ribs of Col2a1-Cre;Apc15lox/15lox mutants at E16.5
show abundant bone matrix deposited by osteoblasts,
invariably expressing high levels of nuclear β-catenin.
Since osteoblasts do not express Col2a1, these cells are
most likely derived from Col2a1-expressing skeletal pre-
cursors lacking functional Apc. This implies that, in con-
trast to other skeletal elements, skeletal precursors of the
proximal ribs are able to escape from the noxious effects
of strongly elevated β-catenin levels on differentiation of
precursor cells by an as yet unknown mechanism. Since
Ihh expression is normal in the non-recombined neigh-
bouring chondrocytes, we speculate that Ihh may be a
prime target for inducing osteoblastogenesis in the recom-BMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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bined precursor cells counteracting the noxious effect of
β-catenin.
Despite the evidence of functional osteoclasts, the
intensely ossified proximal ribs show a strongly dimin-
ished bone marrow cavity, rendering it likely that the
increased bone formation is due to osteosclerosis. These
observations are in agreement with other data, showing
that enhanced canonical Wnt signaling can increase bone
mass through stimulation of osteoblast activity rather
than inhibition of osteoclast formation and activity [39-
41]. Such an osteopetrotic phenotype has only been seen
in mice with conditional loss of functional Apc or consti-
tutively active β-catenin in already differentiated osteob-
lasts, resulting in dramatically increased bone deposition
[17,42].
Functional Apc is required to maintain the chondrocyte 
phenotype
We have found clear evidence for the occurrence of
chondrocyte dedifferentiation due to β-catenin accumula-
tion in the nasal septum. Morphologically characterized
chondrocytes, which were nuclear β-catenin-positive,
lacked expression of typical chondrocyte markers. Fur-
thermore, they were imbedded in an ECM containing sig-
nificantly less proteoglycans.
Given the noxious effect of increased β-catenin levels on
chondrocyte formation (our data and [12,15]), these cells
most likely have undergone Cre-mediated loss of func-
tional  Apc  after completion of the initial stages of
chondrocyte differentiation. Mouse models with an
increased level of β-catenin in Col2a1-expressing cells
show accelerated chondrocyte maturation [11,12]. We
have found no indication for this phenomenon, implying
that the high level of β-catenin due to loss of Apc does not
result in chondrocyte maturation but in chondrocyte ded-
ifferentiation. Our data suggest that accumulated β-cat-
enin triggers this dedifferentiation program not only
through inhibition of chondrogenic marker expression
but also by enhancing the loss of ECM presumably
through stimulation of matrix-degrading enzymes. It has
been demonstrated that β-catenin increases expression
and activity of a number of enzymes involved in matrix
degradation [43-45]. β-Catenin stabilization has been
associated with dedifferentiation of articular chondro-
cytes in vitro upon serial monolayer culture, or treatment
with retinoic acid or IL1β [46]. Dedifferentiated chondro-
cytes have also been observed at other sites of endochon-
dral bone formation in the Col2a1-Cre;Apc15lox/15lox
embryos, however, the presence of these cells was most
pronounced in the nasal septum. Altogether, our data
indicate that Apc is required to suppress β-catenin for
maintenance of the chondrocytic phenotype.
Conclusion
We show here for the first time that Apc, by negatively
controlling the levels of β-catenin, is a critical regulator of
the differentiation of skeletal progenitor cells. Condi-
tional inactivation of the mouse Apc gene results in a het-
erogeneous skeletal phenotype. Based on our results, we
postulate that Apc-mediated control of the dosage of tran-
scriptionally active β-catenin protein is directive for the
differentiation program of skeletal precursor cells. In the
vast majority of the skeletal precursors, loss of functional
Apc leads to a strongly increased β-catenin level, resulting
in the formation of an undifferentiated mesenchymal cell,
which lacks differentiation potential for both osteogenic
and chondrogenic lineages. When the inhibitory effect of
a strongly increased β-catenin level in the skeletal precur-
sors is reduced, highly active osteoblasts arise. Strong
repression of β-catenin in these precursors is required for
chondrogenesis. Support for our hypothesis on the
importance of the dosage of Apc and β-catenin is provided
by observations in Col2a1-Wnt14 transgenic mice [11].
Higher levels of Wnt14 expression resulting in a high level
of β-catenin block differentiation of skeletal precursors
into chondrocytes or osteoblasts, whereas lower levels of
Wnt14 expression result in enhanced ossification. We pro-
vide evidence that Apc plays a crucial role in modulating
the β-catenin level during mouse skeletogenesis in a spa-
tio-temporal regulated manner. In skeletal precursor cells,
Apc is required for differentiation into both chondrocytes
and osteoblasts. In addition, Apc is essential in chondro-




All animal studies were approved by the ethical commit-
tee of the Leiden University Medical Centre and complied
with national laws relating to the conduct of animal
experiments. The Apc15lox/+ mouse was generated by gene
targeting in IB10 embryonic stem cells, using a 22.5 kb
targeting vector containing loxP  sites flanking the last
exon of Apc, i.e. exon 15. LoxP sites were inserted in the
BglII site of intron 14 and in the ApaI site approximately
350 bp downstream of the Apc polyadenylation signal.
Exon 15 of the Apc gene encodes for codons 660 to 2842
of the Apc protein and harbours all the functional
domains of Apc involved in β-catenin regulation as well as
the C-terminal domains binding to microtubules, DLG,
and EB1. Therefore, following Cre-mediated deletion of
exon 15, functionality of the remaining protein will be
fully impaired with respect to the main function of Apc,
i.e. β-catenin regulating. Moreover, as deletion of exon 15
also removes the polyadenylation signal, no stable mRNA
is produced and as a consequence no stable truncated pro-
tein will be generated. A full description of this new con-BMC Developmental Biology 2009, 9:26 http://www.biomedcentral.com/1471-213X/9/26
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ditional  Apc  mouse model is currently in preparation
(Robanus-Maandag et al., in preparation). Col2a1-Cre
mice [27] were mated with Apc15lox/15lox mice. Of the off-
spring, Col2a1-Cre+/-;Apc15lox/+  mice were mated with
Apc15lox/15lox  mice to obtain Col2a1-Cre+/-;Apc15lox/15lox
mice. LacZ reporter mice were obtained from Dr. Xiao-
hong Mao [28]. Routine mouse genotyping was per-
formed on tail DNAs by PCR (Robanus-Maandag et al., in
preparation).
Skeletal analysis
Skeletons of mouse embryos were stained with Alcian
blue and Alizarin red for cartilaginous and mineralized
tissues, respectively, according to standard procedures
[47]. For micro-computed tomography (μCT) analysis,
femora were recovered from 12-week-old mice after death
and processed as described [48].
β-galactosidase staining, Histology, 
Immunohistochemistry, In Situ Hybridization
Whole mount β-galactosidase staining was performed as
described [49], from E16.5 on after removal of the skin.
For histology, immunohistochemistry, and in situ hybrid-
ization, specimens were fixed in phosphate-buffered for-
malin, embedded in paraffin, and sectioned at 6 μm.
Hematoxylin/eosin, Nuclear red, Toluidine blue, and von
Kossa stainings were performed according to standard
procedures. For immunohistochemistry, sections were
treated with 1% H2O2 in 40% methanol/60% TBS for 30
minutes to reduce endogenous peroxidase activity. For
antigen retrieval the sections were boiled in Tris-EDTA pH
9.0 for 20 minutes. Blocking was performed with 5%
blocking buffer for 30 minutes at 37°C (Boehringer Ingel-
heim). Sections were incubated with the primary mouse
monoclonal antibody against β-catenin (1:100; BD Trans-
duction Laboratories) overnight at 4°C, followed by incu-
bation with the second antibody biotin-conjugated rabbit
anti-mouse IgG (1:300; Amersham Biosciences) for 45
minutes at 37°C. The biotinylated proteins were detected
by incubation with horseradish peroxidase-conjugated
streptavidin (1:200; Amersham Biosciences) for 30 min-
utes at 37°C and visualized with DAB (Sigma). After
counterstaining with Alcian blue for 15 minutes and
hematoxylin for 1 minute, sections were dehydrated and
embedded in Histomount (BDH). For in situ hybridiza-
tion, digoxigenin-labeled single-stranded RNA probes
were prepared using a DIG RNA labeling kit (Boehringer)
following the manufacturers' instructions. All probes are
available upon request. In situ hybridization was carried
out as described [15,50]. Images were taken with a DXM-
1200 digital camera (Nikon).
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